Literature DB >> 36018524

Prediction of Individual Lymph Node Metastatic Status in Esophageal Squamous Cell Carcinoma Using Routine Computed Tomography Imaging: Comparison of Size-Based Measurements and Radiomics-Based Models.

Chenyi Xie1,2, Yihuai Hu3,4, Varut Vardhanabhuti5, Hong Yang6, Lujun Han7, Jianhua Fu3.   

Abstract

BACKGROUND: Lymph node status is vital for prognosis and treatment decisions for esophageal squamous cell carcinoma (ESCC). This study aimed to construct and evaluate an optimal radiomics-based method for a more accurate evaluation of individual regional lymph node status in ESCC and to compare it with traditional size-based measurements.
METHODS: The study consecutively collected 3225 regional lymph nodes from 530 ESCC patients receiving upfront surgery from January 2011 to October 2015. Computed tomography (CT) scans for individual lymph nodes were analyzed. The study evaluated the predictive performance of machine-learning models trained on features extracted from two-dimensional (2D) and three-dimensional (3D) radiomics by different contouring methods. Robust and important radiomics features were selected, and classification models were further established and validated.
RESULTS: The lymph node metastasis rate was 13.2% (427/3225). The average short-axis diameter was 6.4 mm for benign lymph nodes and 7.9 mm for metastatic lymph nodes. The division of lymph node stations into five regions according to anatomic lymph node drainage (cervical, upper mediastinal, middle mediastinal, lower mediastinal, and abdominal regions) improved the predictive performance. The 2D radiomics method showed optimal diagnostic results, with more efficient segmentation of nodal lesions. In the test set, this optimal model achieved an area under the receiver operating characteristic curve of 0.841-0.891, an accuracy of 84.2-94.7%, a sensitivity of 65.7-83.3%, and a specificity of 84.4-96.7%.
CONCLUSIONS: The 2D radiomics-based models noninvasively predicted the metastatic status of an individual lymph node in ESCC and outperformed the conventional size-based measurement. The 2D radiomics-based model could be incorporated into the current clinical workflow to enable better decision-making for treatment strategies.
© 2022. Society of Surgical Oncology.

Entities:  

Year:  2022        PMID: 36018524     DOI: 10.1245/s10434-022-12207-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   4.339


  36 in total

1.  Prognostic factors in patients with squamous oesophageal cancer associated with solitary lymph node metastasis after oesophagectomy and extended lymphadenectomy.

Authors:  Masashi Takemura; Harushi Osugi; Nobuyasu Takada; Hiroaki Kinoshita; Masayuki Higashino
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

2.  Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer.

Authors:  Jeongmin Choi; Sang Gyun Kim; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Surg Endosc       Date:  2009-12-24       Impact factor: 4.584

3.  What should be the gold standard for the surgical component in the treatment of locally advanced esophageal cancer: transthoracic versus transhiatal esophagectomy.

Authors:  Asad Kutup; Michael F Nentwich; Elfriede Bollschweiler; Dean Bogoevski; Jakob R Izbicki; Arnulf H Hölscher
Journal:  Ann Surg       Date:  2014-12       Impact factor: 12.969

4.  Numeric pathologic lymph node classification shows prognostic superiority to topographic pN classification in esophageal squamous cell carcinoma.

Authors:  Kotaro Sugawara; Hiroharu Yamashita; Yukari Uemura; Takashi Mitsui; Koichi Yagi; Masato Nishida; Susumu Aikou; Kazuhiko Mori; Sachiyo Nomura; Yasuyuki Seto
Journal:  Surgery       Date:  2017-07-21       Impact factor: 3.982

5.  Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.

Authors:  Thomas W Rice; Hemant Ishwaran; Wayne L Hofstetter; Paul H Schipper; Kenneth A Kesler; Simon Law; E M R Lerut; Chadrick E Denlinger; Jarmo A Salo; Walter J Scott; Thomas J Watson; Mark S Allen; Long-Qi Chen; Valerie W Rusch; Robert J Cerfolio; James D Luketich; Andre Duranceau; Gail E Darling; Manuel Pera; Carolyn Apperson-Hansen; Eugene H Blackstone
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

6.  Comparative study of computed tomography (CT) and pathological diagnosis toward mediastinal lymph node metastasis in esophageal carcinoma.

Authors:  Jiancheng Li; Shanshan Chen; Guangying Zhu
Journal:  Rev Assoc Med Bras (1992)       Date:  2018-02       Impact factor: 1.209

7.  Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.

Authors:  Hiroyuki Kato; Hiroyuki Kuwano; Masanobu Nakajima; Tatsuya Miyazaki; Minako Yoshikawa; Hitoshi Ojima; Katsuhiko Tsukada; Noboru Oriuchi; Tomio Inoue; Keigo Endo
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

8.  Clinical implication of the innovations of the 8th edition of the TNM classification for esophageal and esophago-gastric cancer.

Authors:  Xavier Benoit D'Journo
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

9.  Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.

Authors:  Emmanuel Gabriel; Kristopher Attwood; William Du; Rebecca Tuttle; Raed M Alnaji; Steven Nurkin; Usha Malhotra; Steven N Hochwald; Moshim Kukar
Journal:  JAMA Surg       Date:  2016-03       Impact factor: 14.766

10.  Optimum lymphadenectomy for esophageal cancer.

Authors:  Nabil P Rizk; Hemant Ishwaran; Thomas W Rice; Long-Qi Chen; Paul H Schipper; Kenneth A Kesler; Simon Law; Toni E M R Lerut; Carolyn E Reed; Jarmo A Salo; Walter J Scott; Wayne L Hofstetter; Thomas J Watson; Mark S Allen; Valerie W Rusch; Eugene H Blackstone
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.